Luma Vision Ltd.
Clinical trials sponsored by Luma Vision Ltd., explained in plain language.
-
New heart mapping technology aims to improve irregular heartbeat treatment
Disease control Not yet recruitingThis study is testing a new navigation and imaging system called VERAFEYE during heart ablation procedures for people with paroxysmal atrial fibrillation (a type of irregular heartbeat). The goal is to see if doctors can successfully create detailed 3D maps of the heart and compl…
Sponsor: LUMA Vision Ltd. • Aim: Disease control
Last updated Mar 23, 2026 15:18 UTC
-
Doctors track new heart mapping tool in Real-World use
Knowledge-focused Not yet recruitingThis study aims to collect real-world information on how well a new 3D imaging system, called VERAFEYE, works during standard heart procedures. It will enroll 50 adults who are already scheduled for a procedure to treat an irregular heartbeat (atrial fibrillation) or to close off…
Sponsor: LUMA Vision Ltd. • Aim: Knowledge-focused
Last updated Mar 27, 2026 12:38 UTC